Stan Berenshteyn
Stock Analyst at Wells Fargo
(0.36)
# 4,297
Out of 4,579 analysts
288
Total ratings
49.7%
Success rate
-5.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintained: Buy | $320 | $194.46 | +64.56% | 40 | Jul 22, 2026 | |
| AMWL American Well | Rated: Buy | $9 → $16 | $11.05 | +44.80% | 17 | Jul 17, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | $1.75 | $2.15 | -18.60% | 26 | Jul 16, 2026 | |
| OMCL Omnicell | Maintained: Buy | $55 | $41.49 | +32.56% | 54 | Jul 2, 2026 | |
| HNGE Hinge Health | Rated: Buy | $80 → $90 | $75.11 | +19.82% | 5 | Jun 24, 2026 | |
| DOCS Doximity | Maintained: Hold | $18 | $20.99 | -14.24% | 32 | Jun 10, 2026 | |
| HQY HealthEquity | Rated: Buy | $125 | $99.05 | +26.20% | 55 | Jun 5, 2026 | |
| GDRX GoodRx Holdings | Maintained: Buy | $3.5 | $3.05 | +14.75% | 35 | Jun 2, 2026 | |
| PHR Phreesia | Reiterated: Hold | $9 | $10.63 | -15.33% | 6 | May 28, 2026 | |
| OMDA Omada Health | Maintained: Hold | $17 → $18 | $20.58 | -12.54% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $8.91 | -32.66% | 8 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $30 → $22 | $21.82 | +0.82% | 3 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 → $36 | $23.13 | +55.68% | 2 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $15.15 | n/a | 1 | Oct 6, 2015 |
Veeva Systems
Jul 22, 2026
Maintained: Buy
Price Target: $320
Current: $194.46
Upside: +64.56%
American Well
Jul 17, 2026
Rated: Buy
Price Target: $9 → $16
Current: $11.05
Upside: +44.80%
Health Catalyst
Jul 16, 2026
Maintained: Hold
Price Target: $1.75
Current: $2.15
Upside: -18.60%
Omnicell
Jul 2, 2026
Maintained: Buy
Price Target: $55
Current: $41.49
Upside: +32.56%
Hinge Health
Jun 24, 2026
Rated: Buy
Price Target: $80 → $90
Current: $75.11
Upside: +19.82%
Doximity
Jun 10, 2026
Maintained: Hold
Price Target: $18
Current: $20.99
Upside: -14.24%
HealthEquity
Jun 5, 2026
Rated: Buy
Price Target: $125
Current: $99.05
Upside: +26.20%
GoodRx Holdings
Jun 2, 2026
Maintained: Buy
Price Target: $3.5
Current: $3.05
Upside: +14.75%
Phreesia
May 28, 2026
Reiterated: Hold
Price Target: $9
Current: $10.63
Upside: -15.33%
Omada Health
May 8, 2026
Maintained: Hold
Price Target: $17 → $18
Current: $20.58
Upside: -12.54%
Apr 30, 2026
Maintained: Hold
Price Target: $6
Current: $8.91
Upside: -32.66%
Mar 19, 2026
Rated: Hold
Price Target: $30 → $22
Current: $21.82
Upside: +0.82%
Feb 19, 2026
Reiterated: Buy
Price Target: $41 → $36
Current: $23.13
Upside: +55.68%
Oct 6, 2015
Initiated Coverage: Buy
Price Target: $34
Current: $15.15
Upside: n/a